Innovation

Pharma is facing the many challenges of COVID-19 head-on. Leading organizations are taking full advantage of today‚Äôs sophisticated analytic tools, including state-of-the-art anonymization technologies that seamlessly link patient data across multiple sources, to monitor the impact of COVID-19 on treatments in new ways.   Since the COVID-19 pandemic began, the industry has been primarily focused on understanding the journey of severely ill, older adults requiring hospitalization. More...

Read More